Skip to content

Epidural Morphine for Analgesia After Traumatic Vaginal Delivery

Efficacy of Two Doses of Epidural Morphine for Analgesia After Traumatic Vaginal Delivery: a Randomized, Double Blinded, Placebo-controlled Pilot Study

Status
Withdrawn
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01689597
Enrollment
0
Registered
2012-09-21
Start date
2012-09-30
Completion date
2013-01-31
Last updated
2017-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Traumatic Vaginal Delivery

Brief summary

This pilot study intends to establish the efficacy of 2 different doses of epidural morphine for pain management after perineal trauma when using multimodal analgesia as well as the feasibility of conducting a larger randomized clinical trial. Women with traumatic vaginal delivery will be randomized into 3 groups with 10 patients each and receive 2.5 mg epidural morphine, 1.25 mg epidural morphine, or epidural saline. The primary outcome is total opioid consumption for breakthrough pain in the first 24 hours.

Interventions

DRUGMorphine

Comparison of different dosages of drug

DRUGPlacebo

Sponsors

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* The patient is 18 years or older * The patient is ASA 1-3 * Gestation 37-42 weeks * The patient had a vaginal delivery * The patient received epidural analgesia for labor and delivery

Exclusion criteria

* The patient has refused to participate * The patient cannot give informed consent * The investigator has significant concerns for maternal or neonatal welfare * The patient has a history of allergy to opioids * The patient has a history of chronic opioid consumption * The patient has a history of narcotic abuse * The patient has an allergy to local anesthetics * The patient has a contraindication to taking NSAIDs or acetaminophen * The patient received combined spinal-epidural analgesia * The patient has a history of chronic pain

Design outcomes

Primary

MeasureTime frame
Total breakthrough opioid consumptionFirst 24 hours after delivery

Secondary

MeasureTime frame
Pain scores with movementAt 6, 12, 24, and 36 h after delivery
Severity of nausea/vomitingAt 6, 12, 24, and 36 h after delivery
Severity of pruritisAt 6, 12, 24, and 36 h after delivery
Severity of sedationAt 6, 12, 24, and 36 h after delivery
Time to first request for additional analgesiaFirst 36 h after delivery
Pain scores at restAt 6, 12, 24, and 36 h after delivery
Quality of RecoveryAt 24 and 36 h after delivery
Antiemetic consumptionFirst 36 h after delivery
Antipruritic medication consumptionFirst 36 h after delivery
Total opioid consumptionFirst 36 h after delivery
Patient satisfaction with pain controlAt 24 and 36 h after delivery

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026